These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


317 related items for PubMed ID: 26884339

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nonphosphorylated tau slows down Aβ1-42 aggregation, binds to Aβ1-42 oligomers, and reduces Aβ1-42 toxicity.
    Beeg M, Battocchio E, De Luigi A, Colombo L, Natale C, Cagnotto A, Corbelli A, Fiordaliso F, Diomede L, Salmona M, Gobbi M.
    J Biol Chem; 2021; 296():100664. PubMed ID: 33865852
    [Abstract] [Full Text] [Related]

  • 3. Protective effect of Terminalia chebula Retz. extract against Aβ aggregation and Aβ-induced toxicity in Caenorhabditis elegans.
    Zhao L, Duan Z, Wang Y, Wang M, Liu Y, Wang X, Li H.
    J Ethnopharmacol; 2021 Mar 25; 268():113640. PubMed ID: 33307058
    [Abstract] [Full Text] [Related]

  • 4. Optimal control strategies for inhibition of protein aggregation.
    Michaels TCT, Weber CA, Mahadevan L.
    Proc Natl Acad Sci U S A; 2019 Jul 16; 116(29):14593-14598. PubMed ID: 31253705
    [Abstract] [Full Text] [Related]

  • 5. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
    Klein AN, Ziehm T, van Groen T, Kadish I, Elfgen A, Tusche M, Thomaier M, Reiss K, Brener O, Gremer L, Kutzsche J, Willbold D.
    ACS Chem Neurosci; 2017 Sep 20; 8(9):1889-1900. PubMed ID: 28581708
    [Abstract] [Full Text] [Related]

  • 6. Secondary nucleation and elongation occur at different sites on Alzheimer's amyloid-β aggregates.
    Scheidt T, Łapińska U, Kumita JR, Whiten DR, Klenerman D, Wilson MR, Cohen SIA, Linse S, Vendruscolo M, Dobson CM, Knowles TPJ, Arosio P.
    Sci Adv; 2019 Apr 20; 5(4):eaau3112. PubMed ID: 31001578
    [Abstract] [Full Text] [Related]

  • 7. Beneficial Effects of Cyclic Ether 2-Butoxytetrahydrofuran from Sea Cucumber Holothuria scabra against Aβ Aggregate Toxicity in Transgenic Caenorhabditis elegans and Potential Chemical Interaction.
    Tangrodchanapong T, Sornkaew N, Yurasakpong L, Niamnont N, Nantasenamat C, Sobhon P, Meemon K.
    Molecules; 2021 Apr 11; 26(8):. PubMed ID: 33920352
    [Abstract] [Full Text] [Related]

  • 8. Resveratrol-mediated cleavage of amyloid β1-42 peptide: potential relevance to Alzheimer's disease.
    Al-Edresi S, Alsalahat I, Freeman S, Aojula H, Penny J.
    Neurobiol Aging; 2020 Oct 11; 94():24-33. PubMed ID: 32512325
    [Abstract] [Full Text] [Related]

  • 9. In vitro studies of the neuroprotective activities of astaxanthin and fucoxanthin against amyloid beta (Aβ1-42) toxicity and aggregation.
    Alghazwi M, Smid S, Musgrave I, Zhang W.
    Neurochem Int; 2019 Mar 11; 124():215-224. PubMed ID: 30639263
    [Abstract] [Full Text] [Related]

  • 10. Toward the Mode of Action of the Clinical Stage All-d-Enantiomeric Peptide RD2 on Aβ42 Aggregation.
    Zhang T, Gering I, Kutzsche J, Nagel-Steger L, Willbold D.
    ACS Chem Neurosci; 2019 Dec 18; 10(12):4800-4809. PubMed ID: 31710458
    [Abstract] [Full Text] [Related]

  • 11. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
    Dai X, Hou W, Sun Y, Gao Z, Zhu S, Jiang Z.
    Int J Mol Sci; 2015 May 08; 16(5):10526-36. PubMed ID: 26006224
    [Abstract] [Full Text] [Related]

  • 12. Inhibiting the Ca2+ Influx Induced by Human CSF.
    Drews A, De S, Flagmeier P, Wirthensohn DC, Chen WH, Whiten DR, Rodrigues M, Vincke C, Muyldermans S, Paterson RW, Slattery CF, Fox NC, Schott JM, Zetterberg H, Dobson CM, Gandhi S, Klenerman D.
    Cell Rep; 2017 Dec 12; 21(11):3310-3316. PubMed ID: 29241555
    [Abstract] [Full Text] [Related]

  • 13. Specific recognition of biologically active amyloid-β oligomers by a new surface plasmon resonance-based immunoassay and an in vivo assay in Caenorhabditis elegans.
    Stravalaci M, Bastone A, Beeg M, Cagnotto A, Colombo L, Di Fede G, Tagliavini F, Cantù L, Del Favero E, Mazzanti M, Chiesa R, Salmona M, Diomede L, Gobbi M.
    J Biol Chem; 2012 Aug 10; 287(33):27796-805. PubMed ID: 22736768
    [Abstract] [Full Text] [Related]

  • 14. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
    Kino R, Araya T, Arai T, Sohma Y, Kanai M.
    Bioorg Med Chem Lett; 2015 Aug 01; 25(15):2972-5. PubMed ID: 26045033
    [Abstract] [Full Text] [Related]

  • 15. A Cationic Zn-Phthalocyanine Turns Alzheimer's Amyloid β Aggregates into Non-Toxic Oligomers and Inhibits Neurotoxicity in Culture.
    Sheikh AM, Tabassum S, Yano S, Abdullah FB, Wang R, Ikeue T, Nagai A.
    Int J Mol Sci; 2024 Aug 16; 25(16):. PubMed ID: 39201616
    [Abstract] [Full Text] [Related]

  • 16. Protection of Si Nanowires against Aβ Toxicity by the Inhibition of Aβ Aggregation.
    Zhao X, Mou C, Xu J, Cui W, Shi Y, Wang Y, Luo T, Guo W, Ye J, Chen W.
    Molecules; 2024 Apr 25; 29(9):. PubMed ID: 38731472
    [Abstract] [Full Text] [Related]

  • 17. Significant combination of Aβ aggregation inhibitory and neuroprotective properties in silico, in vitro and in vivo by bis(propyl)-cognitin, a multifunctional anti-Alzheimer's agent.
    Hu S, Xian Y, Fan Y, Mak S, Wang J, Tang J, Pang Y, Pi R, Tsim KW, Liu F, Lin Z, Han Y.
    Eur J Pharmacol; 2020 Jun 05; 876():173065. PubMed ID: 32171792
    [Abstract] [Full Text] [Related]

  • 18. Aβ(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon.
    Rigacci S, Guidotti V, Bucciantini M, Nichino D, Relini A, Berti A, Stefani M.
    Curr Alzheimer Res; 2011 Dec 05; 8(8):841-52. PubMed ID: 21592051
    [Abstract] [Full Text] [Related]

  • 19. Clusterin inhibits Aβ42 aggregation through a "strawberry model" as detected by FRET-FCS.
    Xu L, Tian S, Peng X, Hua Y, Yang W, Chen L, Liu S, Wu W, Zhao J, He J, Wu L, Yang J, Zheng Y.
    J Neurochem; 2021 Jul 05; 158(2):444-454. PubMed ID: 33694231
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of amyloid-β aggregation in Alzheimer's disease.
    Wang Q, Yu X, Li L, Zheng J.
    Curr Pharm Des; 2014 Jul 05; 20(8):1223-43. PubMed ID: 23713775
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.